Message by Takeda Pharmaceutical Co., Ltd.

Since the invention of iPS cell technology by Professor Yamanaka happened in Japan, we really hope to develop and launch iPSC-derived cell therapies in Japan and deliver them to the patients in the world.

We are currently developing a cell therapy to cure cancer using immune cells derived from iPS cells.

It is my dream to cure cancer using iPSC-derived immune cell therapies.

About the organization

The Takeda Pharmaceutical Company is a global leader in biopharmaceuticals that puts the patient at the center of everything it does. For 240 years since its founding, the company has been dedicated to the creation of innovative medicines and treatments based on an unwavering management ethos.

MORE MESSAGE

SEKISUI CHEMICAL CO., LTD.

Manager/Project Head
Advanced Technology Institute
Life Science Development Center Satoshi HANEDA

Thyas Co., Ltd.

Representative Director, COO/CFORyosuke GONOTSUBO

MESSAGE LIST